Triple thErapy in paTients with COPD under Real lIve Setting (the TETRIS study)

The primary objective is to describe the percentage of participants with diagnosed COPD
with or without comorbid asthma (hereinafter summarized as COPD*) who continuously
receive triple therapy for 6, 12 and 24 months after study enrolment.